DYRK family of protein kinases: Evolutionary relationships, biochemical properties, and functional roles

FASEB Journal

Volumn 25, Issue 2, 2011, Pages 449-462

  Aranda, Sergi ^a,b,d   Laguna, Ariadna ^a,b,e   De La Luna, Susana ^a,b,c  

^a CENTRE FOR GENOMIC REGULATION CRG   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

^c INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

^d KAROLINSKA INSTITUTE   (Sweden)

^e LUDWIG INSTITUTE FOR CANCER RESEARCH   (Sweden)

Author keywords

Cell differentiation; Cell survival; Endocytosis; Phosphorylation

Indexed keywords

DUAL SPECIFICITY TYROSINE REGULATED KINASE; PROTEIN KINASE; UNCLASSIFIED DRUG;

BIOCHEMISTRY; CAENORHABDITIS ELEGANS; CELL DIFFERENTIATION; CELL FUNCTION; CELL STRESS; CELL SURVIVAL; CELLULAR DISTRIBUTION; DICTYOSTELIUM DISCOIDEUM; DROSOPHILA; DROSOPHILA MELANOGASTER; ENDOCYTOSIS; ENZYME ACTIVATION; ENZYME SUBSTRATE; EUKARYOTE; EXON; GENETIC TRANSCRIPTION; HUMAN; LOSS OF FUNCTION MUTATION; MAMMAL; MOLECULAR EVOLUTION; NEMATODE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; REVIEW; SACCHAROMYCES CEREVISIAE; SCHIZOSACCHAROMYCES POMBE; SIGNAL TRANSDUCTION;

ANIMALS; BIOLOGICAL EVOLUTION; FUNGI; HUMANS; MULTIGENE FAMILY; PLANTS; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES;

ANIMALIA; EUKARYOTA; FUNGI; PLANTAE; PROTISTA;

EID: 79551647919     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.10-165837     Document Type: Review

References (103)

1. Manning, G., Whyte, D. B., Martinez, R., Hunter, T., and Sudarsanam, S. (2002) The protein kinase complement of the human genome. Science 298, 1912-1934
2. Hanks, S. K., and Hunter, T. (1995) Protein kinases 6. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification. FASEB J. 9, 576-596
3. Garrett, S., and Broach, J. (1989) Loss of Ras activity in Saccharomyces cerevisiae is suppressed by disruptions of a new kinase gene, YAKI, whose product may act downstream of the cAMP-dependent protein kinase. Genes Dev. 3, 1336-1348
4. Martin, D. E., Soulard, A., and Hall, M. N. (2004) TOR regulates ribosomal protein gene expression via PKA and the Forkhead transcription factor FHL1. Cell 119, 969-979
5. Moriya, H., Shimizu-Yoshida, Y., Omori, A., Iwashita, S., Katoh, M., and Sakai, A. (2001) Yak1p, a DYRK family kinase, translocates to the nucleus and phosphorylates yeast Pop2p in response to a glucose signal. Genes Dev. 15, 1217-1228
6. Bahler, J., and Pringle, J. R. (1998) Pom1p, a fission yeast protein kinase that provides positional information for both polarized growth and cytokinesis. Genes Dev. 12, 1356-1370
7. Martin, S. G., and Berthelot-Grosjean, M. (2009) Polar gradients of the DYRK-family kinase Pom1 couple cell length with the cell cycle. Nature 459, 852-856
8. Moseley, J. B., Mayeux, A., Paoletti, A., and Nurse, P. (2009) A spatial gradient coordinates cell size and mitotic entry in fission yeast. Nature 459, 857-860
9. Bahler, J., and Nurse, P. (2001) Fission yeast Pom1p kinase activity is cell cycle regulated and essential for cellular symmetry during growth and division. EMBO J. 20, 1064-1073
10. Tatebe, H., Nakano, K., Maximo, R., and Shiozaki, K. (2008) Pom1 DYRK regulates localization of the Rga4 GAP to ensure bipolar activation of Cdc42 in fission yeast. Curr. Biol. 18, 322-330
11. Celton-Morizur, S., Racine, V., Sibarita, J. B., and Paoletti, A. (2006) Pom1 kinase links division plane position to cell polarity by regulating Mid1p cortical distribution. J. Cell Sci. 119, 4710-4718
12. Padte, N. N., Martin, S. G., Howard, M., and Chang, F. (2006) The cell-end factor pom1p inhibits mid1p in specification of the cell division plane in fission yeast. Curr. Biol. 16, 2480-2487
13. Souza, G. M., Lu, S., and Kuspa, A. (1998) YakA, a protein kinase required for the transition from growth to development in Dictyostelium. Development 125, 2291-2302
14. Taminato, A., Bagattini, R., Gorjao, R., Chen, G., Kuspa, A., and Souza, G. M. (2002) Role for YakA, cAMP, and protein kinase A in regulation of stress responses of Dictyostelium discoideum cells. Mol. Biol. Cell 13, 2266-2275
15. Raich, W. B., Moorman, C., Lacefield, C. O., Lehrer, J., Bartsch, D., Plasterk, R. H., Kandel, E. R., and Hobert, O. (2003) Characterization of Caenorhabditis elegans homologs of the Down syndrome candidate gene DYRK1A. Genetics 163, 571-580
16. Pellettieri, J., Reinke, V., Kim, S. K., and Seydoux, G. (2003) Coordinate activation of maternal protein degradation during the egg-to-embryo transition in C. elegans. Dev. Cell 5, 451-462
17. Quintin, S., Mains, P. E., Zinke, A., and Hyman, A. A. (2003) The mbk-2 kinase is required for inactivation of MEI-1/katanin in the one-cell Caenorhabditis elegans embryo. EMBO Rep. 4, 1175-1181
18. Pang, K. M., Ishidate, T., Nakamura, K., Shirayama, M., Trzepacz, C., Schubert, C. M., Priess, J. R., and Mello, C. C. (2004) The minibrain kinase homolog, mbk-2, is required for spindle positioning and asymmetric cell division in early C. elegans embryos. Dev. Biol. 265, 127-139
19. Nishi, Y., and Lin, R. (2005) DYRK2 and GSK-3 phosphorylate and promote the timely degradation of OMA-1, a key regulator of the oocyte-to-embryo transition in C. elegans. Dev. Biol. 288, 139-149
20. Shirayama, M., Soto, M. C., Ishidate, T., Kim, S., Nakamura, K., Bei, Y., van den Heuvel, S., and Mello, C. C. (2006) The conserved kinases CDK-1, GSK-3, KIN-19, and MBK-2 promote OMA-1 destruction to regulate the oocyte-to-embryo transition in C. elegans. Curr. Biol. 16, 47-55
21. Stitzel, M. L., Cheng, K. C., and Seydoux, G. (2007) Regulation of MBK-2/Dyrk kinase by dynamic cortical anchoring during the oocyte-to-zygote transition. Curr. Biol. 17, 1545-1554
22. Cheng, K. C., Klancer, R., Singson, A., and Seydoux, G. (2009) Regulation of MBK-2/DYRK by CDK-1 and the pseudophosphatases EGG-4 and EGG-5 during the oocyte-to-embryo transition. Cell 139, 560-572
23. Parry, J. M., Velarde, N. V., Lefkovith, A. J., Zegarek, M. H., Hang, J. S., Ohm, J., Klancer, R., Maruyama, R., Druzhinina, M. K., Grant, B. D., Piano, F., and Singson, A. (2009) EGG-4 and EGG-5 link events of the oocyte-to-embryo transition with meiotic progression in C. elegans. Curr. Biol. 19, 1752-1757
24. Nishi, Y., Rogers, E., Robertson, S. M., and Lin, R. (2008) Polo kinases regulate C. elegans embryonic polarity via binding to DYRK2-primed MEX-5 and MEX-6. Development 135, 687-697
25. Guven-Ozkan, T., Nishi, Y., Robertson, S. M., and Lin, R. (2008) Global transcriptional repression in C. elegans germline precursors by regulated sequestration of TAF-4. Cell 135, 149-160
26. Tejedor, F., Zhu, X. R., Kaltenbach, E., Ackermann, A., Baumann, A., Canal, I., Heisenberg, M., Fischbach, K. F., and Pongs, O. (1995) minibrain: a new protein kinase family involved in postembryonic neurogenesis in Drosophila. Neuron 14, 287-301
27. Lochhead, P. A., Sibbet, G., Kinstrie, R., Cleghon, T., Rylatt, M., Morrison, D. K., and Cleghon, V. (2003) dDYRK2: a novel dual-specificity tyrosine-phosphorylation-regulated kinase in Drosophila. Biochem. J. 374, 381-391
28. Lochhead, P. A., Sibbet, G., Morrice, N., and Cleghon, V. (2005) Activation-loop autophosphorylation is mediated by a novel transitional intermediate form of DYRKs. Cell 121, 925-936
29. Kinstrie, R., Luebbering, N., Miranda-Saavedra, D., Sibbet, G., Han, J., Lochhead, P. A., and Cleghon, V. (2010) Characterization of a domain that transiently converts class 2 DYRKs into intramolecular tyrosine kinases. [Online] Sci. Signal. 3, ra16
30. Gwack, Y., Sharma, S., Nardone, J., Tanasa, B., Iuga, A., Srikanth, S., Okamura, H., Bolton, D., Feske, S., Hogan, P. G., and Rao, A. (2006) A genome-wide Drosophila RNAi screen identifies DYRK-family kinases as regulators of NFAT. Nature 441, 646-650
31. Becker, W., Weber, Y., Wetzel, K., Eirmbter, K., Tejedor, F. J., and Joost, H. G. (1998) Sequence characteristics, subcellular localization, and substrate specificity of DYRK-related kinases, a novel family of dual specificity protein kinases. J. Biol. Chem. 273, 25893-25902
32. Kannan, N., and Neuwald, A. F. (2004) Evolutionary constraints associated with functional specificity of the CMGC protein kinases MAPK, CDK, GSK, SRPK, DYRK, and CK2alpha. Protein Sci. 13, 2059-2077
33. Kassis, S., Melhuish, T., Annan, R. S., Chen, S. L., Lee, J. C., Livi, G. P., and Creasy, C. L. (2000) Saccharomyces cerevisiae Yak1p protein kinase autophosphorylates on tyrosine residues and phosphorylates myelin basic protein on a C-terminal serine residue. Biochem. J. 348, 263-272
34. Kentrup, H., Becker, W., Heukelbach, J., Wilmes, A., Schurmann, A., Huppertz, C., Kainulainen, H., and Joost, H. G. (1996) Dyrk, a dual-specificity protein kinase with unique structural features whose activity is dependent on tyrosine residues between subdomains VII and VIII. J. Biol. Chem. 271, 3488-3495
35. Lee, K., Deng, X., and Friedman, E. (2000) Mirk protein kinase is a mitogen-activated protein kinase substrate that mediates survival of colon cancer cells. Cancer Res. 60, 3631-3637
36. Li, K., Zhao, S., Karur, V., and Wojchowski, D. M. (2002) DYRK3 activation, engagement of protein kinase A/cAMP response element-binding protein, and modulation of progenitor cell survival. J. Biol. Chem. 277, 47052-47060
37. Adayev, T., Chen-Hwang, M. C., Murakami, N., Lee, E., Bolton, D. C., and Hwang, Y. W. (2007) Dual-specificity tyrosine phosphorylation-regulated kinase 1A does not require tyrosine phosphorylation for activity in vitro. Biochemistry 46, 7614-7624
38. Himpel, S., Tegge, W., Frank, R., Leder, S., Joost, H. G., and Becker, W. (2000) Specificity determinants of substrate recognition by the protein kinase DYRK1A. J. Biol. Chem. 275, 2431-2438
39. Campbell, L. E., and Proud, C. G. (2002) Differing substrate specificities of members of the DYRK family of arginine-directed protein kinases. FEBS Lett. 510, 31-36
40. Aranda, S., Alvarez, M., Turro, S., Laguna, A., and de la Luna, S. (2008) Sprouty2-mediated inhibition of fibroblast growth factor signaling is modulated by the protein kinase DYRK1A. Mol. Cell. Biol. 28, 5899-5911
41. Lim, S., Jin, K., and Friedman, E. (2002) Mirk protein kinase is activated by MKK3 and functions as a transcriptional activator of HNF1alpha. J. Biol. Chem. 277, 25040-25046
42. Taira, N., Yamamoto, H., Yamaguchi, T., Miki, Y., and Yoshida, K. (2010) ATM augments nuclear stabilization of DYRK2 by inhibiting MDM2 in the apoptotic response to DNA damage. J. Biol. Chem. 285, 4909-4919
43. Kim, D., Won, J., Shin, D. W., Kang, J., Kim, Y. J., Choi, S. Y., Hwang, M. K., Jeong, B. W., Kim, G. S., Joe, C. O., Chung, S. H., and Song, W. J. (2004) Regulation of Dyrk1A kinase activity by 14 -3-3. Biochem. Biophys. Res. Commun. 323, 499-504
44. Alvarez, M., Altafaj, X., Aranda, S., and de la Luna, S. (2007) DYRK1A autophosphorylation on serine residue 520 modulates its kinase activity via 14-3-3 binding. Mol. Biol. Cell 18, 1167-1178
45. Li, D., Jackson, R. A., Yusoff, P., and Guy, G. R. (2010) The direct association of Sprouty-related protein with an EVH1 domain (SPRED) 1 or SPRED2 with DYRK1A modifies substrate/ kinase interactions. [E-pub ahead of print] J. Biol. Chem. doi: 10.1074/jbc.M110.148445
46. Bain, J., Plater, L., Elliott, M., Shpiro, N., Hastie, C. J., McLauchlan, H., Klevernic, I., Arthur, J. S., Alessi, D. R., and Cohen, P. (2007) The selectivity of protein kinase inhibitors: a further update. Biochem. J. 408, 297-315
47. Adayev, T., Chen-Hwang, M. C., Murakami, N., Wegiel, J., and Hwang, Y. W. (2006) Kinetic properties of a MNB/DYRK1A mutant suitable for the elucidation of biochemical pathways. Biochemistry 45, 12011-12019
48. Gockler, N., Jofre, G., Papadopoulos, C., Soppa, U., Tejedor, F. J., and Becker, W. (2009) Harmine specifically inhibits protein kinase DYRK1A and interferes with neurite formation. FEBS J. 276, 6324-6337
49. Seifert, A., Allan, L. A., and Clarke, P. R. (2008) DYRK1A phosphorylates caspase 9 at an inhibitory site and is potently inhibited in human cells by harmine. FEBS J. 275, 6268-6280
50. Laguna, A., Aranda, S., Barallobre, M. J., Barhoum, R., Fernandez, E., Fotaki, V., Delabar, J. M., de la Luna, S., de la Villa, P., and Arbones, M. L. (2008) The protein kinase DYRK1A regulates caspase-9-mediated apoptosis during retina development. Dev. Cell 15, 841-853
51. Kuhn, C., Frank, D., Will, R., Jaschinski, C., Frauen, R., Katus, H. A., and Frey, N. (2009) DYRK1A is a novel negative regulator of cardiomyocyte hypertrophy. J. Biol. Chem. 284, 17320-17327
52. Sacher, F., Moller, C., Bone, W., Gottwald, U., and Fritsch, M. (2007) The expression of the testis-specific Dyrk4 kinase is highly restricted to step 8 spermatids but is not required for male fertility in mice. Mol. Cell. Endocrinol. 267, 80-88
53. Maenz, B., Hekerman, P., Vela, E. M., Galceran, J., and Becker, W. (2008) Characterization of the human DYRK1A promoter and its regulation by the transcription factor E2F1 (Online). BMC Mol. Biol. 9, 30
54. Kim, M. Y., Jeong, B. C., Lee, J. H., Kee, H. J., Kook, H., Kim, N. S., Kim, Y. H., Kim, J. K., Ahn, K. Y., and Kim, K. K. (2006) A repressor complex, AP4 transcription factor and geminin, negatively regulates expression of target genes in nonneuronal cells. Proc. Natl. Acad. Sci. U. S. A. 103, 13074-13079
55. Impey, S., McCorkle, S. R., Cha-Molstad, H., Dwyer, J. M., Yochum, G. S., Boss, J. M., McWeeney, S., Dunn, J. J., Mandel, G., and Goodman, R. H. (2004) Defining the CREB regulon: a genome-wide analysis of transcription factor regulatory regions. Cell 119, 1041-1054
56. Lee, Y., Ha, J., Kim, H. J., Kim, Y. S., Chang, E. J., Song, W. J., and Kim, H. H. (2009) Negative feedback inhibition of NFATc1 by DYRK1A regulates bone homeostasis. J. Biol. Chem. 284, 33343-33351
57. Buratti, E., De Conti, L., Stuani, C., Romano, M., Baralle, M., and Baralle, F. (2010) Nuclear factor TDP-43 can affect selected microRNA levels. FEBS J. 277, 2268-2281
58. Marti, E., Altafaj, X., Dierssen, M., de la Luna, S., Fotaki, V., Alvarez, M., Perez-Riba, M., Ferrer, I., and Estivill, X. (2003) Dyrk1A expression pattern supports specific roles of this kinase in the adult central nervous system. Brain Res. 964, 250-263
59. Wegiel, J., Kuchna, I., Nowicki, K., Frackowiak, J., Dowjat, K., Silverman, W. P., Reisberg, B., DeLeon, M., Wisniewski, T., Adayev, T., Chen-Hwang, M. C., and Hwang, Y. W. (2004) Cell type- and brain structure-specific patterns of distribution of minibrain kinase in human brain. Brain Res. 1010, 69-80
60. Leder, S., Czajkowska, H., Maenz, B., De Graaf, K., Barthel, A., Joost, H. G., and Becker, W. (2003) Alternative splicing variants of dual specificity tyrosine phosphorylated and regulated kinase 1B exhibit distinct patterns of expression and functional properties. Biochem. J. 372, 881-888
61. Deng, X., Ewton, D. Z., Pawlikowski, B., Maimone, M., and Friedman, E. (2003) Mirk/dyrk1B is a Rho-induced kinase active in skeletal muscle differentiation. J. Biol. Chem. 278, 41347-41354
62. Lord, K. A., Creasy, C. L., King, A. G., King, C., Burns, B. M., Lee, J. C., and Dillon, S. B. (2000) REDK, a novel human regulatory erythroid kinase. Blood 95, 2838-2846
63. Zhang, D., Li, K., Erickson-Miller, C. L., Weiss, M., and Wojchowski, D. M. (2005) DYRK gene structure and erythroid-restricted features of DYRK3 gene expression. Genomics 85, 117-130
64. Alvarez, M., Estivill, X., and de la Luna, S. (2003) DYRK1A accumulates in splicing speckles through a novel targeting signal and induces speckle disassembly. J. Cell Sci. 116, 3099-3107
65. Hammerle, B., Carnicero, A., Elizalde, C., Ceron, J., Martinez, S., and Tejedor, F. J. (2003) Expression patterns and subcellular localization of the Down syndrome candidate protein MNB/DYRK1A suggest a role in late neuronal differentiation. Eur. J. Neurosci. 17, 2277-2286
66. Murakami, N., Bolton, D., and Hwang, Y. W. (2009) Dyrk1A binds to multiple endocytic proteins required for formation of clathrin-coated vesicles. Biochemistry 48, 9297-9305
67. Friedman, E. (2007) Mirk/Dyrk1B in cancer. J. Cell. Biochem. 102, 274-279
68. Taira, N., Nihira, K., Yamaguchi, T., Miki, Y., and Yoshida, K. (2007) DYRK2 is targeted to the nucleus and controls p53 via Ser46 phosphorylation in the apoptotic response to DNA damage. Mol. Cell. 25, 725-738
69. Fotaki, V., Dierssen, M., Alcantara, S., Martinez, S., Marti, E., Casas, C., Visa, J., Soriano, E., Estivill, X., and Arbones, M. L. (2002) Dyrk1A haploinsufficiency affects viability and causes developmental delay and abnormal brain morphology in mice. Mol. Cell. Biol. 22, 6636-6647
70. Moller, R. S., Kubart, S., Hoeltzenbein, M., Heye, B., Vogel, I., Hansen, C. P., Menzel, C., Ullmann, R., Tommerup, N., Ropers, H. H., Tumer, Z., and Kalscheuer, V. M. (2008) Truncation of the Down syndrome candidate gene DYRK1A in two unrelated patients with microcephaly. Am. J. Hum. Genet. 82, 1165-1170
71. Bogacheva, O., Bogachev, O., Menon, M., Dev, A., Houde, E., Valoret, E. I., Prosser, H. M., Creasy, C. L., Pickering, S. J., Grau, E., Rance, K., Livi, G. P., Karur, V., Erickson-Miller, C. L., and Wojchowski, D. M. (2008) DYRK3 dual-specificity kinase attenuates erythropoiesis during anemia. J. Biol. Chem. 283, 36665-36675
72. Sitz, J. H., Tigges, M., Baumgartel, K., Khaspekov, L. G., and Lutz, B. (2004) Dyrk1A potentiates steroid hormone-induced transcription via the chromatin remodeling factor Arip4. Mol. Cell. Biol. 24, 5821-5834
73. Kelly, P. A., and Rahmani, Z. (2005) DYRK1A enhances the mitogen-activated protein kinase cascade in PC12 cells by forming a complex with Ras, B-Raf, and MEK1. Mol. Biol. Cell 16, 3562-3573
74. Maddika, S., and Chen, J. (2009) Protein kinase DYRK2 is a scaffold that facilitates assembly of an E3 ligase. Nat. Cell Biol. 11, 409-419
75. Guo, X., Williams, J. G., Schug, T. T., and Li, X. (2010) DYRK1A and DYRK3 promote cell survival through phosphorylation and activation of SIRT1. J. Biol. Chem. 285, 13223-13232
76. Arron, J. R., Winslow, M. M., Polleri, A., Chang, C. P., Wu, H., Gao, X., Neilson, J. R., Chen, L., Heit, J. J., Kim, S. K., Yamasaki, N., Miyakawa, T., Francke, U., Graef, I. A., and Crabtree, G. R. (2006) NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21. Nature 441, 595-600
77. Seifert, A., and Clarke, P. R. (2009) p38alpha- and DYRK1A-dependent phosphorylation of caspase-9 at an inhibitory site in response to hyperosmotic stress. Cell Signal. 21, 1626-1633
78. Kang, J. E., Choi, S. A., Park, J. B., and Chung, K. C. (2005) Regulation of the proapoptotic activity of huntingtin interacting protein 1 by Dyrk1 and caspase-3 in hippocampal neuroprogenitor cells. J. Neurosci. Res. 81, 62-72
79. Chang, H. S., Lin, C. H., Yang, C. H., Yen, M. S., Lai, C. R., Chen, Y. R., Liang, Y. J., and Yu, W. C. (2007) Increased expression of Dyrk1a in HPV16 immortalized keratinocytes enable evasion of apoptosis. Int. J. Cancer 120, 2377-2385
80. Mercer, S. E., Ewton, D. Z., Deng, X., Lim, S., Mazur, T. R., and Friedman, E. (2005) Mirk/Dyrk1B mediates survival during the differentiation of C2C12 myoblasts. J. Biol. Chem. 280, 25788-25801
81. Gao, J., Zheng, Z., Rawal, B., Schell, M. J., Bepler, G., and Haura, E. B. (2009) Mirk/Dyrk1B, a novel therapeutic target, mediates cell survival in non-small cell lung cancer cells. Cancer Biol. Ther. 8, 1671-1679
82. Deng, X., Ewton, D. Z., and Friedman, E. (2009) Mirk/Dyrk1B maintains the viability of quiescent pancreatic cancer cells by reducing levels of reactive oxygen species. Cancer Res. 69, 3317-3324
83. Janumyan, Y., Cui, Q., Yan, L., Sansam, C. G., Valentin, M., and Yang, E. (2008) G0 function of BCL2 and BCL-xL requires BAX, BAK, and p27 phosphorylation by Mirk, revealing a novel role of BAX and BAK in quiescence regulation. J. Biol. Chem. 283, 34108-34120
84. Zou, Y., Ewton, D. Z., Deng, X., Mercer, S. E., and Friedman, E. (2004) Mirk/dyrk1B kinase destabilizes cyclin D1 by phosphorylation at threonine 288. J. Biol. Chem. 279, 27790-27798
85. Deng, X., Mercer, S. E., Shah, S., Ewton, D. Z., and Friedman, E. (2004) The cyclin-dependent kinase inhibitor p27Kip1 is stabilized in G(0) by Mirk/dyrk1B kinase. J. Biol. Chem. 279, 22498-22504
86. Park, J., Oh, Y., Yoo, L., Jung, M. S., Song, W. J., Lee, S. H., Seo, H., and Chung, K. C. (2010) DYRK1A phosphorylates p53 and inhibits proliferation of embryonic neuronal cells. J. Biol. Chem. 285, 31895-31906
87. Yabut, O., Domogauer, J., and D'Arcangelo, G. (2010) Dyrk1A overexpression inhibits proliferation and induces premature neuronal differentiation of neural progenitor cells. J. Neurosci. 30, 4004-4014
88. Benavides-Piccione, R., Dierssen, M., Ballesteros-Yanez, I., Martinez de Lagran, M., Arbones, M. L., Fotaki, V., DeFelipe, J., and Elston, G. N. (2005) Alterations in the phenotype of neocortical pyramidal cells in the Dyrk1A+/- mouse. Neurobiol. Dis. 20, 115-122
89. Scales, T. M., Lin, S., Kraus, M., Goold, R. G., and Gordon- Weeks, P. R. (2009) Nonprimed and DYRK1A-primed GSK3 beta-phosphorylation sites on MAP1B regulate microtubule dynamics in growing axons. J. Cell Sci. 122, 2424-2435
90. Lepagnol-Bestel, A. M., Zvara, A., Maussion, G., Quignon, F., Ngimbous, B., Ramoz, N., Imbeaud, S., Loe-Mie, Y., Benihoud, K., Agier, N., Salin, P. A., Cardona, A., Khung-Savatovsky, S., Kallunki, P., Delabar, J. M., Puskas, L. G., Delacroix, H., Aggerbeck, L., Delezoide, A. L., Delattre, O., Gorwood, P., Moalic, J. M., and Simonneau, M. (2009) DYRK1A interacts with the REST/NRSF-SWI/SNF chromatin remodelling complex to deregulate gene clusters involved in the neuronal phenotypic traits of Down syndrome. Hum. Mol. Genet. 18, 1405-1414
91. Canzonetta, C., Mulligan, C., Deutsch, S., Ruf, S., O'Doherty, A., Lyle, R., Borel, C., Lin-Marq, N., Delom, F., Groet, J., Schnappauf, F., De Vita, S., Averill, S., Priestley, J. V., Martin, J. E., Shipley, J., Denyer, G., Epstein, C. J., Fillat, C., Estivill, X., Tybulewicz, V. L., Fisher, E. M., Antonarakis, S. E., and Nizetic, D. (2008) DYRK1A-dosage imbalance perturbs NRSF/REST levels, deregulating pluripotency and embryonic stem cell fate in Down syndrome. Am. J. Hum. Genet. 83, 388-400
92. Ferron, S. R., Pozo, N., Laguna, A., Aranda, S., Porlan, E., Moreno, M., Fillat, C., de la Luna, S., Sanchez, P., Arbones, M. L., and Farinas, I. (2010) Regulated segregation of kinase Dyrk1A during asymmetric neural stem cell division is critical for EGFR-mediated biased signaling. Cell Stem Cell 7, 367-379
93. Park, J., Song, W. J., and Chung, K. C. (2009) Function and regulation of Dyrk1A: towards understanding Down syndrome. Cell. Mol. Life Sci. 66, 3235-3240
94. Deng, X., Ewton, D. Z., Mercer, S. E., and Friedman, E. (2005) Mirk/dyrk1B decreases the nuclear accumulation of class II histone deacetylases during skeletal muscle differentiation. J. Biol. Chem. 280, 4894-4905
95. Mao, J., Maye, P., Kogerman, P., Tejedor, F. J., Toftgard, R., Xie, W., Wu, G., and Wu, D. (2002) Regulation of Gli1 transcriptional activity in the nucleus by Dyrk1. J. Biol. Chem. 277, 35156-35161
96. Varjosalo, M., Bjorklund, M., Cheng, F., Syvanen, H., Kivioja, T., Kilpinen, S., Sun, Z., Kallioniemi, O., Stunnenberg, H. G., He, W. W., Ojala, P., and Taipale, J. (2008) Application of active and kinase-deficient kinome collection for identification of kinases regulating hedgehog signaling. Cell 133, 537-548
97. Lauth, M., Bergstrom, A., Shimokawa, T., Tostar, U., Jin, Q., Fendrich, V., Guerra, C., Barbacid, M., and Toftgard, R. (2010) DYRK1B-dependent autocrine-to-paracrine shift of Hedgehog signaling by mutant RAS. Nat. Struct. Mol. Biol. 17, 718-725
98. Shi, J., Zhang, T., Zhou, C., Chohan, M. O., Gu, X., Wegiel, J., Zhou, J., Hwang, Y. W., Iqbal, K., Grundke-Iqbal, I., Gong, C. X., and Liu, F. (2008) Increased dosage of Dyrk1A alters alternative splicing factor (ASF)-regulated alternative splicing of tau in Down syndrome. J. Biol. Chem. 283, 28660-28669
99. Pelkmans, L., Fava, E., Grabner, H., Hannus, M., Habermann, B., Krausz, E., and Zerial, M. (2005) Genome-wide analysis of human kinases in clathrin- and caveolae/raft-mediated endocytosis. Nature 3571, 1-9
100. Pelkmans, L., and Zerial, M. (2005) Kinase-regulated quantal assemblies and kiss-and-run recycling of caveolae. Nature 436, 128-133
101. Ryoo, S. R., Jeong, H. K., Radnaabazar, C., Yoo, J. J., Cho, H. J., Lee, H. W., Kim, I. S., Cheon, Y. H., Ahn, Y. S., Chung, S. H., and Song, W. J. (2007) DYRK1A-mediated hyperphosphorylation of tau. A functional link between Down syndrome and Alzheimer disease. J. Biol. Chem. 282, 34850-34857
102. Raaf, L., Noll, C., Cherifi, M., Benazzoug, Y., Delabar, J. M., and Janel, N. (2009) Hyperhomocysteinemia-induced Dyrk1a downregulation results in cardiomyocyte hypertrophy in rats. [E-pub ahead of print] Int. J. Cardiol. doi: 10.1016/j.ijcard.2009.10.043
103. Yamashita, S., Chujo, M., Moroga, T., Anami, K., Tokuishi, K., Miyawaki, M., Kawano, Y., Takeno, S., Yamamoto, S., and Kawahara, K. (2009) DYRK2 expression may be a predictive marker for chemotherapy in non-small cell lung cancer. Anticancer Res. 29, 2753-2757